Apolipoprotein M Attenuates Anthracycline Cardiotoxicity and Lysosomal Injury
Authors:
Open Access
- 4 January 2023
- journal article
- research article
- Published by Elsevier in JACC: Basic To Translational Science
- Vol. 8 (3) , 340-355
Abstract
No abstract availableKeywords
All Related Versions
This publication has 56 references indexed in Scilit:
- Identification of the molecular basis of doxorubicin-induced cardiotoxicityNature Medicine, 2012
- Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and TrastuzumabCirculation: Cardiovascular Imaging, 2012
- Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein MProceedings of the National Academy of Sciences, 2011
- Native and reconstituted HDL protect cardiomyocytes from doxorubicin-induced apoptosisCardiovascular Research, 2009
- Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100Blood, 2009
- Acute Doxorubicin Cardiotoxicity Is Associated With p53-Induced Inhibition of the Mammalian Target of Rapamycin PathwayCirculation, 2009
- High-Density Lipoproteins and Their Constituent, Sphingosine-1-Phosphate, Directly Protect the Heart Against Ischemia/Reperfusion Injury In Vivo via the S1P 3 Lysophospholipid ReceptorCirculation, 2006
- The Sphingosine-1-phosphate Receptors S1P1, S1P2, and S1P3 Function Coordinately during Embryonic AngiogenesisJournal of Biological Chemistry, 2004
- High-penetrance mouse model of acute promyelocytic leukemia with very low levels of PML-RARα expressionBlood, 2003
- Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo.Journal of Clinical Investigation, 1997